Related Experiment Video
Updated: Jul 10, 2026
Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
Published on: January 12, 2015
Extrinsic regulation of cardiomyocyte differentiation of embryonic stem cells
Kang Chen1, Liqun Wu, Zack Z Wang
1Department of Cardiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Insights
Cardiovascular disease causes heart failure due to irreversible cardiomyocyte damage. Embryonic stem cells offer potential for cell therapy, but understanding their differentiation into cardiomyocytes is key for cardiac regeneration.
Area of Science:
- * Regenerative Medicine
- * Stem Cell Biology
- * Cardiovascular Research
Background:
- * Cardiovascular diseases remain a leading global cause of mortality.
- * Ischemic injury causes irreversible damage to cardiomyocytes, leading to heart failure.
- * Adult hearts lack cardiomyocyte regenerative capacity, necessitating cell-based therapies.
Purpose of the Study:
- * To explore the potential of embryonic stem cells (ES cells) as a source for cardiovascular cell therapy.
- * To identify regulatory elements governing ES cell differentiation into cardiomyocytes.
- * To review extrinsic factors influencing cardiomyocyte differentiation from ES cells.
Main Methods:
- * Literature review focusing on extrinsic factors in ES cell differentiation.
- * Analysis of current research on stem cell-based cardiac repair.
- * Synthesis of information on cardiomyocyte development pathways.
Main Results:
- * Embryonic stem cells hold promise for generating cardiovascular cells for transplantation.
- * Knowledge gaps exist regarding the specific regulatory mechanisms controlling ES cell differentiation into cardiomyocytes.
- * Extrinsic factors are crucial regulators at various stages of this differentiation process.
Conclusions:
- * Cell-based therapy using ES cell-derived cardiomyocytes is a potential strategy for treating heart failure.
- * Further research into the extrinsic factors regulating ES cell differentiation is essential for advancing cardiac regeneration.
- * Identifying these factors will pave the way for effective therapeutic applications.
Abstract:
Cardiovascular disease is one of leading causes of death throughout the U.S. and the world. The damage of cardiomyocytes resulting from ischemic injury is irreversible and leads to the development of progressive heart failure, which is characterized by the loss of functional cardiomyocytes. Because cardiomyocytes are unable to regenerate in the adult heart, cell-based therapy of transplantation provides a potential alternative approach to replace damaged myocardial tissue and restore cardiac function. A major roadblock toward this goal is the lack of donor cells; therefore, it is urgent to identify the cardiovascular cells that are necessary for achieving cardiac muscle regeneration. Pluripotent embryonic stem (ES) cells have enormous potential as a source of therapeutic tissues, including cardiovascular cells; however, the regulatory elements mediating ES cell differentiation to cardiomyocytes are largely unknown. In this review, we will focus on extrinsic factors that play a role in regulating different stages of cardiomyocyte differentiation of ES cells.
Related Concept Videos
01:22iPS Cell Differentiation
01:14Maintenance of the ES Cell State